Eupraxia Pharmaceuticals Inc. (EPRX.TO)
CAD 4.59
(-2.34%)
CAD 4.59
(-2.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 209.91 Thousand | 193.27 Thousand | 111.52 Thousand | 116.8 Thousand | 201.93 Thousand | 125.82 Thousand |
| Gross Profit | -209.91 Thousand | -193.27 Thousand | -111.52 Thousand | -116.8 Thousand | -201.93 Thousand | -125.82 Thousand |
| Operating Expenses | 37.92 Million | 23.2 Million | 18.67 Million | 2.24 Million | 6.15 Million | 14.31 Million |
| Selling, General and Administrative Expenses | 9.65 Million | 5.8 Million | 8.88 Million | 1.26 Million | 3.01 Million | 7.54 Million |
| Research and Development Expenses | 27.54 Million | 17.2 Million | 9.67 Million | 859.78 Thousand | 2.94 Million | 6.64 Million |
| Other Expenses | - | - | -2.26 Million | - | 1737.00 | - |
| Cost and Expenses | 37.92 Million | 23.2 Million | 18.67 Million | 2.24 Million | 6.15 Million | 14.31 Million |
| Operating Income | -36.89 Million | -22.63 Million | -20.87 Million | -2.24 Million | -6.14 Million | -14.31 Million |
| Interest Expense | 1.57 Million | 1.58 Million | 1.29 Million | 1.88 Million | 1.46 Million | 142.17 Thousand |
| Income Tax Expense | 48.25 Thousand | 930.51 Thousand | -1.34 Million | 1.86 Million | 1.39 Million | -1.45 Million |
| Earnings before Tax | -39.18 Million | -23.91 Million | -23.36 Million | -4.01 Million | -7.24 Million | -14.83 Million |
| Net Income | -37.39 Million | -23.25 Million | -22.98 Million | -3.99 Million | -7.17 Million | -13.23 Million |
| Earnings Per Share Basic | -1.58 | -1.21 | -1.61 | -0.31 | -0.56 | -1.03 |
| Earnings Per Share Diluted | -1.58 | -1.21 | -1.61 | -0.31 | -0.56 | -1.03 |
| Weighted Average Shares Outstanding | 24.14 Million | 19.28 Million | 14.24 Million | 12.86 Million | 12.86 Million | 12.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.14 Million | 19.28 Million | 14.24 Million | 12.86 Million | 12.86 Million | 12.86 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -37.39 Million | -22.13 Million | -21.96 Million | -2.01 Million | -5.94 Million | -14.56 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 2.97 Million | - | - | - |
| Cost of Revenue | 57.5 Thousand | 50.46 Thousand | 1.48 Million | 209.91 Thousand | 49.9 Thousand | 49.18 Thousand |
| Gross Profit | -57.5 Thousand | -50.46 Thousand | 1.48 Million | -209.91 Thousand | -49.9 Thousand | -49.18 Thousand |
| Operating Expenses | 8.91 Million | 8.97 Million | 6.52 Million | 37.67 Million | 8.88 Million | 7.64 Million |
| Selling, General and Administrative Expenses | 3.52 Million | 3.37 Million | -199.46 Thousand | - | 2.59 Million | 2.84 Million |
| Research and Development Expenses | 5.38 Million | 5.59 Million | 6.87 Million | - | 6.09 Million | 4.68 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 8.96 Million | 9.02 Million | 6.52 Million | 37.88 Million | 8.88 Million | 7.64 Million |
| Operating Income | -8.96 Million | -9.02 Million | -6.34 Million | -37.88 Million | -8.62 Million | -7.44 Million |
| Interest Expense | 281.84 Thousand | 321.14 Thousand | -72.73 Thousand | 1.57 Million | 433.28 Thousand | 563.14 Thousand |
| Income Tax Expense | -6841.34 | 6742.98 | -291.45 Thousand | -89.66 Thousand | 199.02 Thousand | 389.67 Thousand |
| Earnings before Tax | -8.3 Million | -8.29 Million | -4.31 Million | -39.18 Million | -6.54 Million | -8 Million |
| Net Income | -8.21 Million | -8.14 Million | -4.09 Million | -38.08 Million | -6.31 Million | -7.82 Million |
| Earnings Per Share Basic | -0.23 | -0.28 | -0.15 | - | -0.25 | -0.36 |
| Earnings Per Share Diluted | -0.23 | -0.28 | -0.15 | - | -0.25 | -0.36 |
| Weighted Average Shares Outstanding | 35.62 Million | 28.81 Million | 27.3 Million | 24.14 Million | 25.52 Million | 22 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.62 Million | 28.81 Million | 27.3 Million | 24.14 Million | 25.52 Million | 22 Million |
| Gross Margin | - | - | 0.50 | - | - | - |
| EBIT Margin | - | - | -2.13 | - | - | - |
| Profit Margin | - | - | -1.38 | - | - | - |
| EBITDA | -8.91 Million | -8.97 Million | -6.34 Million | - | -8.57 Million | -7.39 Million |
| Earnings Before Tax Margin | - | - | -2.13 | - | - | - |
300800
PYT
STAL
ROVI
TWO-PA
HEAD